Pure Global
NCT06210763

IMT Outcomes in Sufferers of Severe Walking Disabilities and Intensive Care Unit Acquired Weakness

Inspiratory Muscle Training Outcomes in Sufferers of Severe Walking Disabilities and Intensive Care Unit Acquired Weakness
Cairo University·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Intensive Care Unit Acquired Weakness
Drug/Device/Intervention
Threshold IMT and traditional physical therapy program
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Cairo University
Location
Giza, Egypt
Timeline & enrollment
Phase
N/A
Start date
Aug 02, 2023
End date
Mar 30, 2024
Enrollment
40 participants
Primary outcome

Modified Functional Ambulation Category Test

Summary

Intensive care unit-acquired weakness (ICU-acquired weakness) may be caused by a variety of
 different causes. Several studies have shown that ICU-acquired weakness occurs in up to 30%
 of critically ill patients. It affects daily activities, walking, and functional performance

ICD-10 classifications
Acute respiratory failureAcute renal failure with medullary necrosisAcute renal failureAcute renal failure, unspecifiedOther acute renal failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06210763
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06210763 through Pure Global AI's free database. This phase not specified trial is sponsored by Cairo University and is currently Recruiting. The study focuses on Intensive Care Unit Acquired Weakness. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.